A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt

• Prif Awduron: Baher Elezbawy (Awdur), Ahmad Nader Fasseeh (Awdur), Amal Sedrak (Awdur), Randa Eldessouki (Awdur), Mary Gamal (Awdur), Mariam Eldebeiky (Awdur), Hanaa Amer (Awdur), Shimaa Akeel (Awdur), Ahmad Morsy (Awdur), Amira Amin (Awdur), Amr Shafik (Awdur), Sherif Abaza (Awdur), Zoltán Kaló (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Background Multi- criteria decision analysis (MCDA) can assist policymakers in objectively choosing between alternative therapeutic options based on multiple value attributes. Our aim was to create an MCDA tool for the national tenders of off-patent oncology medicines in Egypt. Methods An initial li...